Literature DB >> 15730232

The effect of weight loss on a stable biomarker of inflammation, C-reactive protein.

Marion Dietrich1, Ishwarlal Jialal.   

Abstract

Inflammation is pivotal in all phases of atherosclerosis. Increasing body weight is positively associated with inflammation. Weight loss studies have shown that decreasing body weight significantly decreases C-reactive protein, the prototypic biomarker for inflammation. Reducing inflammation through weight loss could therefore be associated with reduced risk for cardiovascular disease and other obesity-associated chronic diseases.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15730232     DOI： 10.1111/j.1753-4887.2005.tb00107.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN： 0029-6643            Impact factor:   7.110


  17 in total

Review 1.  Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?

Authors:  Stephan J L Bakker; Ron T Gansevoort; Erik M Stuveling; Rijk O B Gans; Dick de Zeeuw
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 2.  The effect of weight loss and dietary fatty acids on inflammation.

Authors:  Sridevi Devaraj; Sidika Kasim-Karakas; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2006-11       Impact factor: 5.113

3.  Cardiovascular biomarkers in the years following pregnancies complicated by hypertensive disorders or delivered preterm.

Authors:  Lauren J Tanz; Jennifer J Stuart; Stacey A Missmer; Eric B Rimm; Jennifer A Sumner; Mary A Vadnais; Janet W Rich-Edwards
Journal:  Pregnancy Hypertens       Date:  2018-04-18       Impact factor: 2.899

4.  Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.

Authors:  Massimo Cugno; Roberto Castelli; Daniela Mari; Enrico Mozzi; Marco Antonio Zappa; Massimo Boscolo-Anzoletti; Giancarlo Roviaro; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2011-01-20       Impact factor: 3.397

5.  Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.

Authors:  Brandon L Pierce; Marian L Neuhouser; Mark H Wener; Leslie Bernstein; Richard N Baumgartner; Rachel Ballard-Barbash; Frank D Gilliland; Kathy B Baumgartner; Bess Sorensen; Anne McTiernan; Cornelia M Ulrich
Journal:  Breast Cancer Res Treat       Date:  2008-04-10       Impact factor: 4.872

6.  Circulating levels of inflammatory cytokines and risk of colorectal adenomas.

Authors:  Sangmi Kim; Temitope O Keku; Christopher Martin; Joseph Galanko; John T Woosley; Jane C Schroeder; Jessie A Satia; Susan Halabi; Robert S Sandler
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

7.  Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.

Authors:  Sheetal Hardikar; Lynn Onstad; Xiaoling Song; Angela M Wilson; Thomas J Montine; Mario Kratz; Garnet L Anderson; Patricia L Blount; Brian J Reid; Emily White; Thomas L Vaughan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-08       Impact factor: 4.254

Review 8.  Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

Authors:  Signe Holm Nielsen; Alan J Mouton; Kristine Y DeLeon-Pennell; Federica Genovese; Morten Karsdal; Merry L Lindsey
Journal:  Matrix Biol       Date:  2017-12-14       Impact factor: 11.583

9.  Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?

Authors:  Virginia B Kraus; Joanne M Jordan
Journal:  Biomark Insights       Date:  2007-02-07

10.  Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management.

Authors:  Antoine Kossaify; Annie Garcia; Sami Succar; Antoine Ibrahim; Nicolas Moussallem; Mikhael Kossaify; Gilles Grollier
Journal:  Biomark Insights       Date:  2013-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.